The Guardian has become one of the latest companies to stop posting on X, formerly Twitter, since Elon Musk's takeover of the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This is already possible, but it is far from cheap. For example, without a subscription, the Medtronic Guardian Connect system costs around $5,000 CAN ($3,700 USD) per year, in large part thanks to ...

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. The company’s diabetes segment lags behind competitors like DexCom and Abbott due to ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

To educate people on importance of being ethically conscious, aware, choosing the right path in case of conflict of interest and speak-up without fear when they see anything unethical. To make it ...

and also in comparison to Medtronic's Guardian. Now we could argue that Dexcom might be able to grow at a higher pace but that top-line growth has to come from taking market share. And in my ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Guardian’s exit underscores a worrying trend for X ... They include the likes of Best Buy, Target, Medtronic, 3M, ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...

With this approval, Medtronic is now the first and only company with two PFA technologies available for patients with Afib. The PulseSelect™ Pulsed Field Ablation System, which was FDA approved ...